Published in Drug Week, August 25th, 2006
According to a study from the United States, "CC chemokine receptor (CCR) 3 is a chemokine receptor implicated in recruiting cells, particularly eosinophils (E Phi), to the lung in episodes of allergic asthma. To investigate the efficacy of selective, small-molecule antagonists of CCR3, we developed a murine model of E Phi recruitment to the lung."
"Murine eotaxin was delivered intranasally to mice that had previously received i.p. injections of ovalbumin (OVA), and the effects were monitored by bronchoalveolar lavage. A selective eosinophilic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.